This inventor holds 36 USPTO granted patents and 15 published patent applications, plus 10 CIPO patents and 8 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Abbvie Stemcentrx LLC, Stemcentrx, Inc., Agensys, Inc.. Active years: 2009-2025.
Location History:
- Los Angeles, CA (US) (2009 - 2012)
- Foster City, CA (US) (2015 - 2021)
Company Filing History:
17 out of 40 
14 out of 18 
3 out of 199 
Years Active: 2009-2025
Areas of Expertise:
Title: Innovations and Contributions of Hui Shao in California's Biotech Sector
Introduction
Hui Shao is a prominent inventor based in Foster City, California, known for developing innovative solutions in the biotechnology field. With an impressive portfolio of 32 patents, Shao has made significant contributions, particularly in the area of T-cell therapies.
Latest Patents
Among his latest patents is the invention titled "Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof." This application focuses on agents that specifically bind to an epitope unique to δ3 γδ TCR. These agents, which may include antibodies or their fragments, are pivotal for expanding or selectively expanding δ3 γδ T cells, thereby providing novel methods for treating patients in need. Another noteworthy patent involves "Light chain variable regions," where he introduces novel modulators, including antibodies and their derivatives. These modulators are designed for the treatment of proliferative disorders, showcasing Shao's versatility in addressing complex medical challenges.
Career Highlights
Hui Shao has collaborated with well-known companies like AbbVie and Stemcentrx, LLC, where he has been instrumental in advancing research and development initiatives. His work in these organizations has allowed him to deliver innovative solutions that align with the needs of the medical community.
Collaborations
Throughout his career, Shao has worked alongside notable individuals in the field, including Orit Foord and Robert A. Stull. These collaborations have not only enriched his research perspective but have also amplified the impact of his inventions in the biotechnology domain.
Conclusion
Hui Shao's innovative contributions, particularly in T-cell therapy and antibody technology, are paving the way for advancements in cancer treatment and other proliferative disorders. His expertise and collaborations reflect a profound commitment to improving healthcare outcomes through cutting-edge research and development. Shao's work continues to inspire future generations of inventors in the biotech sector.